Literature DB >> 35876593

Asbestos danger in central Europe is not yet over - the situation in the Czech Republic.

Miroslav Urban1, Daniela Pelclová2, Pavel Urban1, Michael Vít1, Peter Urban1, Zdenka Fenclová1,2.   

Abstract

OBJECTIVES: In the Czech Republic, asbestos has been classified as a known human carcinogen since 1984. The use of asbestos-containing products was limited to scenarios where the use of other materials was not possible. Since 1997, the manufacture of asbestos materials has been forbidden, and in 1999, the import, manufacture and distribution of all types of asbestos fibres was legally banned by Act No. 157/1998 Coll. Although the use of asbestos is forbidden, the risk of exposure still exists given the ongoing demolition and reconstruction of buildings in which asbestos has been used. In addition, a novel risk has arisen through the quarrying of asbestos-containing aggregates and their subsequent use. The aim of this paper was to describe and evaluate asbestos in terms of history, legislation, current risk of occupational exposure and its health consequences in the Czech Republic over the last three decades.
METHODS: This retrospective descriptive study used the collected data on occupational exposure and occupational diseases. The counts of workers occupationally exposed to asbestos were obtained from the Registry of Work Categorization; the numbers and structure of occupational diseases caused by asbestos were taken from the Czech National Registry of Occupational Diseases. Data on the total number of mesothelioma cases recorded in the Czech National Cancer Registry was provided by the Institute of Health Information and Statistics of the Czech Republic.
RESULTS: A total of 13,112 subjects were registered as occupationally exposed to asbestos during the period 2001-2020. A total of 687 cases of asbestos-related occupational diseases were reported in the period 1991-2020 in the Czech Republic, comprising 178 cases of asbestosis, 250 cases of pleural hyalinosis, 168 cases of pleural or peritoneal mesothelioma, 90 cases of lung cancer, and one case of laryngeal cancer. The data from the Czech National Cancer Registry, available for a shorter period (1991-2018), reveal 1,389 cases of mesothelioma, of which only ~11% were recognised as occupational, despite the fact that the occupational causality of mesotheliomas is estimated to be up to 90% of mesotheliomas. Moreover, the latency of mesotheliomas since the last occupational exposure reached up to 50 years and this trend is still slightly increasing, unlike asbestosis, where a high cumulative dose of inhaled asbestos is needed. The real proportion of occupational lung cancers may obviously be even higher, especially in smokers, where occupational causes including asbestos are not suspected by most physicians.
CONCLUSION: Czech data on asbestos-related occupational diseases, especially cancers, are grossly underestimated, which is most apparent through the low proportion of mesotheliomas diagnosed as occupational. Asbestos materials in older buildings remained in situ and may represent a danger during reconstruction works. The current source of exposure appears to be quarrying of asbestos-containing aggregate and its subsequent use. Awareness of the professional community is therefore crucial, not only for the possibility of compensating those affected, but also for the early detection of the diseases through the dispensary of exposed persons.

Entities:  

Keywords:  asbestos; asbestos ban; asbestos-related diseases; unrecognised occupational diseases; work categorization

Mesh:

Substances:

Year:  2022        PMID: 35876593     DOI: 10.21101/cejph.a7094

Source DB:  PubMed          Journal:  Cent Eur J Public Health        ISSN: 1210-7778            Impact factor:   1.154


  9 in total

1.  Guidelines for mineral fibre analyses in biological samples: report of the ERS Working Group. European Respiratory Society.

Authors:  P De Vuyst; A Karjalainen; P Dumortier; J C Pairon; E Monsó; P Brochard; H Teschler; A Tossavainen; A Gibbs
Journal:  Eur Respir J       Date:  1998-06       Impact factor: 16.671

2.  Significance of serum mesothelin in an asbestos-exposed population in the Czech Republic.

Authors:  Petr Jakubec; Daniela Pelclova; Petra Smolkova; Vitezslav Kolek; Marie Nakladalova
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2014-04-29       Impact factor: 1.245

3.  Asbestos fibers in ovarian tissue from Norwegian pulp and paper workers.

Authors:  H Langseth; B V Johansen; J M Nesland; K Kjaerheim
Journal:  Int J Gynecol Cancer       Date:  2007 Jan-Feb       Impact factor: 3.437

4.  Malignant mesothelioma and asbestos exposure in Europe: Evidence of spatial clustering.

Authors:  Ewa Wilk; Małgorzata Krówczyńska
Journal:  Geospat Health       Date:  2021-05-14       Impact factor: 1.212

5.  The rise and fall in incidence of malignant mesothelioma from a British Naval Dockyard, 1979-1999.

Authors:  A K Hilliard; J K Lovett; C R McGavin
Journal:  Occup Med (Lond)       Date:  2003-05       Impact factor: 1.611

6.  [Mesothelioma].

Authors:  I Tischoff; A Tannapfel
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

7.  Long-term epidemiological observation of asbestos-related diseases in Poland, 1970-2015.

Authors:  B Swiatkowska; N Szeszenia-Dabrowska
Journal:  Occup Med (Lond)       Date:  2017-04-01       Impact factor: 1.611

8.  Mesothelioma Mortality Rates in Greece for the Period 2005-2015 Is Increased Compared to Previous Decades.

Authors:  Evdoxia Gogou; Chrissi Hatzoglou; Sotirios G Zarogiannis; Foteini Malli; Rajesh M Jagirdar; Konstantinos I Gourgoulianis
Journal:  Medicina (Kaunas)       Date:  2019-07-30       Impact factor: 2.430

Review 9.  Asbestos, Smoking and Lung Cancer: An Update.

Authors:  Sonja Klebe; James Leigh; Douglas W Henderson; Markku Nurminen
Journal:  Int J Environ Res Public Health       Date:  2019-12-30       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.